Bone Biologics Corp. BBLG 深 滬
已收盤 02-06 16:00:00 美东时间
1.40
+0.035
+2.56%
華盛通- 最 高1.44
- 今 開1.3292
- 成交量 2.84万股
- 最 低 1.30
- 昨 收 1.365
- 總市值 251.34万
- 52周最高 7.50
- 市盈率 靜 --
- 換手率 1.58%
- 52周最低 1.30
- 委 比 -73.91%
- 總股本 179.53万
- 歷史最高 10255.68
- 量 比 1.17
- 振 幅 10.26%
- 歷史最低 1.30
- 每 手 1
- 風險率 1.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 54.7% to $1.38 du...
2025-12-24 01:05
Bone Biologics Extends Shelf Life Of rhNELL‑1 To 24 Months, Meeting Forecasts
Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW))), a developer of orthobiologic products for spine fusion markets, announces it has received confirmation that the shelf life of its
2025-12-23 21:06
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_BBLG_Sorensen.pdf
2025-11-18 01:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during ...
2025-09-04 20:08
Bone Biologics CEO Issues Stockholder Letter Highlighting NB1 Clinical Progress, Product Improvements, Year-End Enrollment Goal, Expanded Shelf Life, Interim Trial Update, And 2026 Financial Outlook
One-Year OutlookThe firm expect to achieve a number of value-creating events in the coming year under our cost-efficient business model, including the following:Adding additional hospital sites in Australia and
2025-09-04 19:08
Bone Biologics Q2 EPS $(1.33) Misses $(0.58) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0.58) by 129.31 percent. This is a 66.92 percent increase over losses of $(4.02) per share from
2025-08-15 05:50
Why Is Bone Biologics Stock Surging On Friday?
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.
2025-06-27 22:23
Bone Biologics shares are trading higher after the compnay announced it filed a USPTO patent for rhNELL-1.
Bone Biologics shares are trading higher after the compnay announced it filed a...
2025-06-27 20:16
Market-Moving News for June 27th
NKE: 11% | Nike Q4 Earnings: Revenue Beat, EPS Beat, Headwinds Expected To Moderate Moving Forward, Company Playing 'Sport Offense' BBLG: 188% | Bone Biologics Files USPTO Patent For rhNELL-1 Protein In
2025-06-27 19:22
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Plus Therapeutics (NASDAQ:PSTV) stock increased by 66.2% to $0.31 duri...
2025-06-26 01:06
